| Literature DB >> 34188939 |
H Traore1, E Sogodogo2, A Coulibaly1, A Toure1, S Thiocary1, M D Sidibé1, L G Timbiné2, A K Sangaré2, B Y Traoré2, J Ouedraogo2, D Sogodogo3, B Kouriba2.
Abstract
Noma or cancrum oris is a multi-bacterial and opportunistic infection that destroys soft tissue, as well as muscle and bone, and can be fatal. We present a rare case of Noma in a 32-year-old Malian woman, from whom we isolated an Escherichia coli extended-spectrum beta-lactamase.Entities:
Keywords: Antibiotic; Escherichia coli; Mali; Noma; cancrum oris
Year: 2021 PMID: 34188939 PMCID: PMC8219893 DOI: 10.1016/j.nmni.2021.100907
Source DB: PubMed Journal: New Microbes New Infect ISSN: 2052-2975
Fig. 1Physical sequelae of NOMA in a 32-year-old woman.
Fig. 2Isolation of Extended-Spectrum β-lactamase (ESBL) producing Escherichia coli. The formation of a zone of inhibition between the three antibiotics is observed. AMC: amoxicillin/acid clavulanic; FEP: Cefepime, CRO: ceftriaxone.
Antimicrobial susceptibilities of Escherichia coli isolate obtained from a 32-year-old woman
| Antibiotics | Results |
|---|---|
| Imipenem | Sensitive |
| Ertapenem | Sensitive |
| Colistin | Sensitive |
| Fosfomycin | Sensitive |
| Gentamycin | Sensitive |
| Amikacin | Sensitive |
| Nitrofurantoin | Sensitive |
| Pipéracilline/Tazobactam | Sensitive |
| Amoxicillin-clavulanic acid | Intermediate |
| Cefepime | Intermediate |
| Amoxicillin | Resistant |
| Trimethoprim-sulfamethoxazole | Resistant |
| Ceftriaxone | Resistant |
| Doxycycline | Resistant |
| Cefalotine | Resistant |
| Ciprofloxacin | Resistant |